A call to action to address the steatotic liver disease public health threat in Barcelona

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Lazarus, Jeffrey V.
  • dc.contributor.author Miralles-Sanchez, J. Emilio
  • dc.contributor.author Agirre-Garrido, Leire
  • dc.contributor.author Brachowicz, Nicolai
  • dc.contributor.author Nicolàs, Aina
  • dc.contributor.author Armenta, Anthony
  • dc.contributor.author Boudou, Delfina
  • dc.contributor.author Rice-Duek, Lisa
  • dc.contributor.author Pericàs, Juan
  • dc.contributor.author Benach, Joan
  • dc.contributor.author Kopka, Christopher J.
  • dc.contributor.author Wajcman, Dana Ivancovsky
  • dc.date.accessioned 2025-06-23T09:33:58Z
  • dc.date.available 2025-06-23T09:33:58Z
  • dc.date.issued 2025
  • dc.date.updated 2025-06-23T09:33:58Z
  • dc.description.abstract Despite their high prevalence worldwide, steatotic liver diseases (SLDs) are largely excluded from most non-communicable disease (NCD) guidelines and strategies. We propose policies and strategies to achieve the United Nations Sustainable Development Goal of reducing NCD premature mortality by one-third by 2030. To assess this gap -the exclusion of SLDs from NCD policies- in urban areas, we reviewed Barcelona's strategies for NCD risks (e.g., alcohol, tobacco, healthy food access). We then explored applications of geo-spatial visualisation and whole-of-society approaches (e.g., citizen science engagement) aligned with the World Health Organization (WHO) Best Buys to provide recommendations to address NCDs, generally, and SLDs specifically.
  • dc.description.sponsorship Funds from European Commission/EFPIA IMI2 853966-2, IMI2 777377, H2020 847989, HLTH-2023-TOOL-05-03, ISCIII PI19/01898 and PI22/01770, MICIN IBEC_ProyectCompl22, DTS24/00035, and "La Caixa" Foundation and Barcelona City Council (COVID-SHINE and StopALD). JB reports having received grants or contracts for "Study of the drivers of late diagnosis of alcohol related disease, alone or in combination with metabolic-dysfunction associated fatty liver disease (MAFLD), and implementation and evaluation of interventions to reduce its burden (StopALD)", ID: 22S07286-001. Barcelona City Council. 2022-2024. EM, LAG NB, AN, AA, DB, LR, CJK, DIW declare that they have no conflicts of interest. JVL, JEMS, LAG, NB, AN, AA, DB, LRD, and DIW acknowledge support to ISGlobal from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Lazarus JV, Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Armenta A, et al. A call to action to address the steatotic liver disease public health threat in Barcelona. Lancet Reg Health Eur. 2025 May;52:101272. DOI: 10.1016/j.lanepe.2025.101272
  • dc.identifier.doi http://dx.doi.org/10.1016/j.lanepe.2025.101272
  • dc.identifier.issn 2666-7762
  • dc.identifier.uri http://hdl.handle.net/10230/70744
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.relation.ispartof The Lancet Regional Health - Europe. 2025 May;52:101272
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/847989
  • dc.rights © 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
  • dc.subject.keyword Liver disease
  • dc.subject.keyword Health policy
  • dc.subject.keyword City health
  • dc.subject.keyword Citizen science
  • dc.subject.keyword Sustainable development goals
  • dc.title A call to action to address the steatotic liver disease public health threat in Barcelona
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion